U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.529_546del (p.Pro177_Cys182del) AND Li-Fraumeni syndrome 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 14, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004031305.1

Allele description [Variation Report for NM_000546.6(TP53):c.529_546del (p.Pro177_Cys182del)]

NM_000546.6(TP53):c.529_546del (p.Pro177_Cys182del)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.529_546del (p.Pro177_Cys182del)
HGVS:
  • NC_000017.11:g.7675073_7675090del
  • NG_017013.2:g.17468_17485del
  • NM_000546.4:c.529_546delCCCCACCATGAGCGCTGC
  • NM_000546.6:c.529_546delMANE SELECT
  • NM_001126112.3:c.529_546del
  • NM_001126113.3:c.529_546del
  • NM_001126114.3:c.529_546del
  • NM_001126115.2:c.133_150del
  • NM_001126116.2:c.133_150del
  • NM_001126117.2:c.133_150del
  • NM_001126118.2:c.412_429del
  • NM_001276695.3:c.412_429del
  • NM_001276696.3:c.412_429del
  • NM_001276697.3:c.52_69del
  • NM_001276698.3:c.52_69del
  • NM_001276699.3:c.52_69del
  • NM_001276760.3:c.412_429del
  • NM_001276761.3:c.412_429del
  • NP_000537.3:p.Pro177_Cys182del
  • NP_001119584.1:p.Pro177_Cys182del
  • NP_001119585.1:p.Pro177_Cys182del
  • NP_001119586.1:p.Pro177_Cys182del
  • NP_001119587.1:p.Pro45_Cys50del
  • NP_001119588.1:p.Pro45_Cys50del
  • NP_001119589.1:p.Pro45_Cys50del
  • NP_001119590.1:p.Pro138_Cys143del
  • NP_001263624.1:p.Pro138_Cys143del
  • NP_001263625.1:p.Pro138_Cys143del
  • NP_001263626.1:p.Pro18_Cys23del
  • NP_001263627.1:p.Pro18_Cys23del
  • NP_001263628.1:p.Pro18_Cys23del
  • NP_001263689.1:p.Pro138_Cys143del
  • NP_001263690.1:p.Pro138_Cys143del
  • LRG_321t1:c.529_546del
  • LRG_321:g.17468_17485del
  • NC_000017.10:g.7578384_7578401del
  • NC_000017.10:g.7578391_7578408del
  • NM_000546.5:c.529_546del
  • NM_000546.6:c.529_546del
Links:
dbSNP: rs2073361326
Molecular consequence:
  • NM_000546.6:c.529_546del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126112.3:c.529_546del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126113.3:c.529_546del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126114.3:c.529_546del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126115.2:c.133_150del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126116.2:c.133_150del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126117.2:c.133_150del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001126118.2:c.412_429del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276695.3:c.412_429del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276696.3:c.412_429del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276697.3:c.52_69del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276698.3:c.52_69del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276699.3:c.52_69del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276760.3:c.412_429del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001276761.3:c.412_429del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Li-Fraumeni syndrome 1 (LFS)
Identifiers:
Gene: 553989; MedGen: C1835398; Orphanet: 524; OMIM: 151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004933252Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Likely pathogenic
(Feb 14, 2024)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.

Chen JY, Funk WD, Wright WE, Shay JW, Minna JD.

Oncogene. 1993 Aug;8(8):2159-66.

PubMed [citation]
PMID:
8336941

A novel p53 mutant retained functional activity in lung carcinomas.

Ko JL, Chiao MC, Chang SL, Lin P, Lin JC, Sheu GT, Lee H.

DNA Repair (Amst). 2002 Sep 4;1(9):755-62.

PubMed [citation]
PMID:
12509279
See all PubMed Citations (5)

Details of each submission

From Myriad Genetics, Inc., SCV004933252.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant is considered likely pathogenic. This variant is expected to disrupt protein structure [Myriad internal data]. Functional studies indicate this variant impacts protein function [PMID: 8336941, 12509279, 17530187]. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 16633321, 21590121].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 12, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search